NCT04109625View on ClinicalTrials.gov

Preliminary Validation of an in Vitro Diagnosis-medical Device for Hepatitis B Screening

NACompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

October 21, 2019

Primary Completion Date

May 13, 2022

Study Completion Date

May 13, 2022

Conditions

Hepatitis BHealthyDiagnoses Disease

Interventions

DIAGNOSTIC_TEST

Demonstrator MAGIA

test of capillary blood with the demonstrator at two time and 2 measures and 2 finger by subject.

Trial Locations (1)

38000

Clinical research center CIC1406, Grenoble

Sponsors

Collaborators (1)

MagIA Diagnostics

All Listed Sponsors

collaborator

MagIA Diagnostics

INDUSTRY

lead

University Hospital, Grenoble

OTHER

NCT04109625 - Preliminary Validation of an in Vitro Diagnosis-medical Device for Hepatitis B Screening | Biotech Hunter | Biotech Hunter